BR122012015772B8 - compostos de imidazol fundidos a atila ou heteroarila - Google Patents

compostos de imidazol fundidos a atila ou heteroarila

Info

Publication number
BR122012015772B8
BR122012015772B8 BR122012015772A BR122012015772A BR122012015772B8 BR 122012015772 B8 BR122012015772 B8 BR 122012015772B8 BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 A BR122012015772 A BR 122012015772A BR 122012015772 B8 BR122012015772 B8 BR 122012015772B8
Authority
BR
Brazil
Prior art keywords
atyl
imidazole compounds
heteroaryl fused
fused imidazole
heteroaryl
Prior art date
Application number
BR122012015772A
Other languages
English (en)
Portuguese (pt)
Other versions
BR122012015772B1 (pt
BR122012015772A2 (enrdf_load_stackoverflow
BR122012015772A8 (pt
Inventor
Kawai Akiyoshi
Taniguchi Kana
Shinjyo Katsuhiro
Nakao Kazunari
Matsumizu Miyako
Uneo Naomi
Nukui Seiji
Kato Tomoki
Miyake Yoriko
Hashizume Yoshinobu
Okumura Yoshiyuki
Original Assignee
Askat Inc
Raqualia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Askat Inc, Raqualia Pharma Inc filed Critical Askat Inc
Priority claimed from PCT/IB2001/001940 external-priority patent/WO2002032900A2/en
Publication of BR122012015772A2 publication Critical patent/BR122012015772A2/pt
Publication of BR122012015772A8 publication Critical patent/BR122012015772A8/pt
Publication of BR122012015772B1 publication Critical patent/BR122012015772B1/pt
Publication of BR122012015772B8 publication Critical patent/BR122012015772B8/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR122012015772A 2000-10-19 2001-10-15 compostos de imidazol fundidos a atila ou heteroarila BR122012015772B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24182500P 2000-10-19 2000-10-19
US60/241,825 2000-10-19
BRPI0114704 2001-10-15
PCT/IB2001/001940 WO2002032900A2 (en) 2000-10-19 2001-10-15 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents

Publications (4)

Publication Number Publication Date
BR122012015772A2 BR122012015772A2 (enrdf_load_stackoverflow) 2004-02-25
BR122012015772A8 BR122012015772A8 (pt) 2017-10-03
BR122012015772B1 BR122012015772B1 (pt) 2018-05-02
BR122012015772B8 true BR122012015772B8 (pt) 2021-05-25

Family

ID=62103641

Family Applications (1)

Application Number Title Priority Date Filing Date
BR122012015772A BR122012015772B8 (pt) 2000-10-19 2001-10-15 compostos de imidazol fundidos a atila ou heteroarila

Country Status (1)

Country Link
BR (1) BR122012015772B8 (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
BR122012015772B1 (pt) 2018-05-02
BR122012015772A2 (enrdf_load_stackoverflow) 2004-02-25
BR122012015772A8 (pt) 2017-10-03

Similar Documents

Publication Publication Date Title
BRPI0117360A2 (pt) inibidores de proteína de quinase de 2-indolinona de pirrol substituído, seus sais e composições farmacêuticas compreendendo os mesmos
NO20032187L (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
DE602004032496D1 (de) Hierarchisches, Netzwerk basiertes Emulationssystem
ATE299875T1 (de) Benzoamid-piperidin verbindungen als substanz p- antagonisten
DE60037345D1 (de) Pyrroloi2,3-d pyrimidinderivate enthaltende Zusammensetzungen
ATE423120T1 (de) Pyrroloä2,3-düpyrimidin verbindungen als immunosuppressive wirkstoffe
DE60119777D1 (de) Pyrazolverbindungen als protein-kinasehemmer
DE60119749D1 (de) Pyrazolverbindungen als protein-kinasehemmer
DE60130841D1 (de) Phasendetektor
DE60139494D1 (de) Biaxial streckbares absorbierendes kleidungsstück
ATE298748T1 (de) (1,4')-bipiperidin verbindungen
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
DE60118569D1 (de) 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten
DE60116202D1 (de) Perkutan absorbierende Zubereitung
DE60114852D1 (de) Chinazolin-derivate als alpha-1 adrenerge antagonisten
WO2001086448A3 (en) A diagnostic tool for a portable thread environment
DE60223702D1 (de) Epoxidation in dichter phase
DK1322651T3 (da) Bicykliske, heteroaromatiske forbindelser
BR122012015772B8 (pt) compostos de imidazol fundidos a atila ou heteroarila
DK1261588T3 (da) Imidazolforbindelser som alfa2-adrenoceptorantagonister
DE50110971D1 (de) Werkzeughalter
IT1318501B1 (it) Detergenti cutanei contenenti melanine.
NO20026246L (no) 2-aminoalkyl-tieno[2,3-d]pyrimidiner
ITRN20000043A0 (it) Macchina utensile per la lavorazione del legno con sistema computazionale integrato
BR0116387B1 (pt) antitranspirante/desodorante em bastço de alta eficÁcia sem Álcool estearÍlico adicionado.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25G Requested change of headquarter approved

Owner name: RAQUALIA PHARMA INC. (JP)

B25A Requested transfer of rights approved

Owner name: RAQUALIA PHARMA INC. (JP)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: ASKAT INC. (JP)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/10/2021